Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607919848121) titled 'A CLINICAL STUDY TO EVALUATE THE EFFECTS OF NXT007 COMPARED TO EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A' on July 31.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Permuted block randomization,Allocation Sequence/Code was not concealed
Primary Sponsor: F. HoffmannLa Roche Ltd
Condition:
Haematological Disorders
Haematological Disorders
Intervention:
NXT007 Test Product
Recruitment Status: Not Recruiting
Phase: Phase-3
Date of First Enrollment: 31/07/2026
Target Sample Size: 8
Countries of Recruit...